StockData
DarioHealth Corp. logo

DarioHealth Corp. (DRIO) income statement

DRIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/3098% below fair value
$1.44−0.02 (-1.37%)

Close on Nov 19, 2026Market cap $14.11MP/E 0.4Yield –

DarioHealth Corp. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
58.2%
Operating margin
-151.6%
Net margin
-169.9%
Return on equity, FY2025
-59.6%

Financial strength

Current ratio
2.31
Debt to equity
0.56
Debt to assets
32.2%
Cash to current liabilities
69.3%

Valuation

P/E ratio
0.4
Price to sales
0.67
Price to book
0.26
Dividend yield
–

See a number that looks wrong?